New Drug Might Lower Both Bad Cholesterol and Blood Sugar
This press release is an announcement submitted by WelChol, and was not written by Diabetes Health.
In two recent studies, WelChol, a drug already approved for lowering LDL (bad) cholesterol was found to lower A1c's in patients with type 2 diabetes. The first study showed that WelChol, when added to insulin, lowered A1c's by an average of 0.5% compared to a placebo group.
In the second study, WelChol added to an oral antidiabetic therapy again resulted in mean A1c reductions of 0.5% compared to the placebo group.
As a result of these findings, the manufacturer has applied for approval to market their drug as a one-two punch for both cholesterol and type 2 diabetes. If approved, it will be the first drug to target both conditions.
* * *
Source: WelChol Press ReleaseClick Here To View Or Post Comments